Panel discussion: Why is it so important to connect with other women in bio? Opening remarks - Susan Sobolov, Connecticut Chapter Chair and Lisa Iannucci, Executive...

Designing and selecting appropriate lead candidates is key in reducing clinical attrition and costs associated with the development of new drugs. To ensure a smooth...

DNA-encoded library (DEL) technology has the potential to revolutionize drug discovery. In the last decade, the technology has become a mainstay within the industry for its...

Did you know… The U.S. Department of Health and Human Services is one of the largest sources of early-stage capital for life sciences in the U.S.?...

Climate change is the greatest public policy challenge facing this generation. New approaches are required at almost every level of the economy. Biotechnology has the...

Calling all companies! The Yale Life Science Career Fair brings together exciting companies with graduating students at Yale. This year, the career fair will be...

Identifying and progressing drug candidates with the best overall drug safety profile and establishing a well-characterized translational risk profile is key in reducing clinical attrition...

Collaboration with large pharma and biotech through strategic partnering deals can represent a critical component of an early-stage biopharma ventures de-risking process. It can also...

Please join J.P. Morgan to learn how international, national and regional advancements in biomedical research and development are impacting the Connecticut landscape. As a follow-up...

Southern Connecticut State University, along with BioPath (Bioscience Academic and Career Pathway Initiative), and The Jackson Laboratory, invite you to attend the Bioscience Career Forum....